Related Experiment Video
Updated: Jul 16, 2025
07:51
Refined Murine Model of Idiopathic Pulmonary Fibrosis
Published on: June 17, 2025
135
Pulmonary fibrosis: from pathogenesis to clinical decision-making
Thomas Koudstaal1, Manuela Funke-Chambour2, Michael Kreuter3
1Department of Pulmonary Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands.
Trends in Molecular Medicine
|September 16, 2023
Summary
Pulmonary fibrosis (PF) involves progressive lung scarring, leading to breathing difficulties and reduced quality of life. This review explores current insights into PF
Area of Science:
- Pulmonary Medicine
- Pathophysiology
- Fibrotic Lung Diseases
Background:
- Pulmonary fibrosis (PF) is a group of chronic lung diseases affecting the interstitium.
- These conditions impair gas exchange, causing breathlessness and reduced quality of life (QoL).
- PF is linked to abnormal wound healing, inflammation, and excessive fibrosis, with diverse underlying causes often classified as interstitial lung diseases (ILDs).
Purpose of the Study:
- To provide an in-depth review of current knowledge on pulmonary fibrosis.
- To explore the latest insights into PF pathophysiology, diagnosis, and treatment.
- To discuss future perspectives in managing PF.
Main Methods:
- Literature review of recent research on pulmonary fibrosis.
- Synthesis of information on PF pathogenesis, molecular mechanisms, and clinical aspects.
- Analysis of current diagnostic and therapeutic strategies.
Main Results:
- PF pathogenesis involves complex molecular mechanisms, often stemming from abnormal wound healing responses.
- Despite progress, the precise mechanisms driving PF remain incompletely understood.
- Current treatments aim to manage symptoms and slow disease progression, but curative options are limited.
Conclusions:
- Pulmonary fibrosis is a complex condition with significant impact on patient QoL and survival.
- Further research into PF pathophysiology is crucial for developing effective treatments.
- Future directions include targeted therapies and improved diagnostic approaches for ILDs.
Related Concept Videos
01:20COPD: Pathogenesis and Clinical Features
333
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
333
01:30Pulmonary Hypertension: Classification and Pathogenesis
216
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
There are various classifications for PH, each relating to different underlying causes and also...
216
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.8K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.8K
01:29Pneumonia II: Pathophysiology
323
The pathophysiology of pneumonia involves the following steps:
323
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.8K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.8K